397 related articles for article (PubMed ID: 38369469)
21. Dual role of microbiota-derived short-chain fatty acids on host and pathogen.
Mirzaei R; Dehkhodaie E; Bouzari B; Rahimi M; Gholestani A; Hosseini-Fard SR; Keyvani H; Teimoori A; Karampoor S
Biomed Pharmacother; 2022 Jan; 145():112352. PubMed ID: 34840032
[TBL] [Abstract][Full Text] [Related]
22. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.
Yang T; Richards EM; Pepine CJ; Raizada MK
Nat Rev Nephrol; 2018 Jul; 14(7):442-456. PubMed ID: 29760448
[TBL] [Abstract][Full Text] [Related]
23. Microbial Regulation of Host Physiology by Short-chain Fatty Acids.
van der Hee B; Wells JM
Trends Microbiol; 2021 Aug; 29(8):700-712. PubMed ID: 33674141
[TBL] [Abstract][Full Text] [Related]
24. Fecal microbiota transplantation and replenishment of short-chain fatty acids protect against chronic cerebral hypoperfusion-induced colonic dysfunction by regulating gut microbiota, differentiation of Th17 cells, and mitochondrial energy metabolism.
Su SH; Wu YF; Lin Q; Zhang L; Wang DP; Hai J
J Neuroinflammation; 2022 Dec; 19(1):313. PubMed ID: 36567333
[TBL] [Abstract][Full Text] [Related]
25. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health.
Nogal A; Valdes AM; Menni C
Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33764858
[TBL] [Abstract][Full Text] [Related]
26. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
Gonçalves P; Araújo JR; Di Santo JP
Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
[TBL] [Abstract][Full Text] [Related]
27. Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy.
Luu M; Monning H; Visekruna A
Front Immunol; 2020; 11():1225. PubMed ID: 32612610
[TBL] [Abstract][Full Text] [Related]
28. Role of microbiota-derived short-chain fatty acids in nervous system disorders.
Mirzaei R; Bouzari B; Hosseini-Fard SR; Mazaheri M; Ahmadyousefi Y; Abdi M; Jalalifar S; Karimitabar Z; Teimoori A; Keyvani H; Zamani F; Yousefimashouf R; Karampoor S
Biomed Pharmacother; 2021 Jul; 139():111661. PubMed ID: 34243604
[TBL] [Abstract][Full Text] [Related]
29. The gut-lung axis in severe acute Pancreatitis-associated lung injury: The protection by the gut microbiota through short-chain fatty acids.
Wang Z; Liu J; Li F; Luo Y; Ge P; Zhang Y; Wen H; Yang Q; Ma S; Chen H
Pharmacol Res; 2022 Aug; 182():106321. PubMed ID: 35752356
[TBL] [Abstract][Full Text] [Related]
30. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites.
Koh A; De Vadder F; Kovatcheva-Datchary P; Bäckhed F
Cell; 2016 Jun; 165(6):1332-1345. PubMed ID: 27259147
[TBL] [Abstract][Full Text] [Related]
31. The role of short-chain fatty acids in central nervous system diseases.
Dong Y; Cui C
Mol Cell Biochem; 2022 Nov; 477(11):2595-2607. PubMed ID: 35596843
[TBL] [Abstract][Full Text] [Related]
32. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
[TBL] [Abstract][Full Text] [Related]
33. Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease.
Wang S; Lv D; Jiang S; Jiang J; Liang M; Hou F; Chen Y
Clin Sci (Lond); 2019 Sep; 133(17):1857-1870. PubMed ID: 31467135
[TBL] [Abstract][Full Text] [Related]
34. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
35. Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury.
Li Y; Zhang Y; Wei K; He J; Ding N; Hua J; Zhou T; Niu F; Zhou G; Shi T; Zhang L; Liu Y
Front Cell Infect Microbiol; 2021; 11():577236. PubMed ID: 34307184
[TBL] [Abstract][Full Text] [Related]
36. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
[TBL] [Abstract][Full Text] [Related]
37. Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids.
Kim CH
Cell Mol Immunol; 2021 May; 18(5):1161-1171. PubMed ID: 33850311
[TBL] [Abstract][Full Text] [Related]
38. Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis.
Wang J; Zhu N; Su X; Gao Y; Yang R
Cells; 2023 Mar; 12(5):. PubMed ID: 36899929
[TBL] [Abstract][Full Text] [Related]
39. Gut microbial-derived short-chain fatty acids and bone: a potential role in fracture healing.
Wallimann A; Magrath W; Thompson K; Moriarty T; Richards RG; Akdis CA; O'Mahony L; Hernandez CJ
Eur Cell Mater; 2021 Apr; 41():454-470. PubMed ID: 33881768
[TBL] [Abstract][Full Text] [Related]
40. Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease.
Wu IW; Gao SS; Chou HC; Yang HY; Chang LC; Kuo YL; Dinh MCV; Chung WH; Yang CW; Lai HC; Hsieh WP; Su SC
Theranostics; 2020; 10(12):5398-5411. PubMed ID: 32373220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
